Early recovery of microvascular perfusion induced by t-PA in combination with abciximab or eptifibatide during postischemic reperfusion

BACKGROUND: GPIIb/IIIa inhibitors abciximab and eptifibatide have been shown to inhibit platelet aggregation in ischemic heart disease. Our aim was to test the efficacy of abiciximab (Reo Pro) or eptifibatide (Integrilin) alone or in combination with plasminogen activator (t-PA) in an experimental m...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertuglia, Silva, Giusti, Andrea
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2002
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC117121/
https://www.ncbi.nlm.nih.gov/pubmed/12086588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC117121/
https://www.ncbi.nlm.nih.gov/pubmed/12086588

Ejemplares similares